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Forkhead Factor, FOXO3a, Induces Apoptosis of
Endothelial Cells Through Activation of
Matrix Metalloproteinases
Hae-Young Lee, Hyun-Jung You, Joo-Yun Won, Seock-Won Youn, Hyun-Jai Cho, Kyung-Woo Park,
Woong-Yang Park, Jeong-Sun Seo, Young-Bae Park, Kenneth Walsh, Byung-Hee Oh, Hyo-Soo Kim
Background—The forkhead factor, FOXO3a, is known to induce apoptosis in endothelial cells (ECs). However, its effects
on extracellular matrices (ECM), which are important in EC survival, remained unknown. Here, we evaluated the role
of FOXO3a on EC-ECM interaction.
Methods and Results—Constitutively active FOXO3a was transduced to human umbilical vein endothelial cells by
adenoviral vector (Ad-TM-FOXO3a). Ad-TM-FOXO3a transfection led to dehiscence of ECs from fibronectin-coated
plates, resulting in anoikis, which was significantly reversed by matrix metalloproteinase (MMP) inhibitor, GM6001.
FOXO3a increased the expression of MMP-3 (stromelysin-1) but decreased the expression of tissue inhibitors of
metalloproteinases-1 (TIMP-1), which was associated with increased MMP enzymatic activity in zymography.
Pathophysiologic conditions such as serum starvation or heat shock also induced activation of endogenous FOXO3a,
leading to activation of MMP-3 and apoptosis, which was reversed by GM6001. Delivery of Ad-TM-FOXO3a to the
intraluminal surface in vivo led to EC denudation, disrupted vascular integrity, and impaired endothelium-dependent
vasorelaxation.
Conclusion—Activation of MMPs and possible ECM disruption represent novel mechanisms of FOXO3a-mediated
apoptosis in ECs. (Arterioscler Thromb Vasc Biol. 2008;28:302-308)
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Cell-to-cell and cell-to-matrix contacts are pivotal for themaintenance of survival in anchorage-dependent cells
such as endothelial cells (ECs).1 Withdrawal of anchorage-
dependent cells from their association with the ECM is
known to result in anoikis, a type of apoptosis that is induced
by inadequate cell-to-matrix interactions,2,3 and proteolysis of
adherens junctions disrupting endothelial monolayer integrity
is known to induce apoptosis.4,5
The forkhead factors, which were identified as important
downstream molecules of phosphoinositide-3-OH kinase
(PI3K)/Akt pathway,6,7 are known to play important roles in
the regulation of apoptosis,6,8 cell cycle arrest,8,9 and adapta-
tion to cellular stress.10,11 The forkhead factors have been also
reported to serve essential roles in the maintenance of
vascular stability.12 Various pathophysiologic conditions in-
cluding hyperglycemia13 have been shown to activate fork-
head factors, whereas vascular protecting factors such as
shear stress14,15 and statins16 are reported to inhibit forkhead
factors in blood vessels. FOXO3a, a member of the forkhead
factor family, has been reported to induce apoptosis in
vascular smooth muscle cells,6,17,18 as well as in endothelial
cells.7,19 However, the mechanism of FOXO3a-mediated
apoptosis in ECs is still unclear and has not yet been fully
defined.
In the present study, we identify a novel action of FOXO3a
in the regulation of EC-ECM interaction. We found that the
activation of FOXO3a induced detachment of endothelial
cells from ECM through the activation of matrix
metalloproteinase-3 (MMP-3, also called as stromelysin-1)
and the suppression of tissue inhibitor of metalloproteinase-1
(TIMP-1). Here, we specify the functional significance of
increased MMP activity by FOXO3a signaling in regulating
EC survival and vascular integrity.
Materials and Methods
For expanded methods, please see the supplemental materials, available
online at http://atvb.ahajournals.org.
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Cell Culture, Adenoviral Vectors, and siRNA
Four to 6 passage human umbilical vein endothelial cells (HUVECs;
Clonetics) were seeded on 2% gelatin-coated (Sigma) culture plates
and incubated in endothelial growth medium (EGM bullet kit,
Clonetics) with 10% fetal bovine serum.
Cell Viability and Apoptosis Assay
Viability of HUVECs was quantified using tetrazolium salt, WST-1,
as instructed by the manufacturer (Roche). Apoptosis after 24 hours
of adenoviral vector transfection was determined by measuring the
hypodiploid fragmented DNA content using fluorescence-activated-
cell sorter (FACS) analysis.20
Real-Time Polymerase Chain Reaction Analysis
Changes in RNA-expression of MMP-3 was determined by quanti-
tative real-time polymerase chain reaction (PCR) as previously
described.7
Immunoblot Analysis
Immunoblot analysis was performed by modification of the proce-
dures described previously.21
Casein and Gelatin Zymography
Zymography was performed using a previously described method.22
Immunofluorescent Staining
For immunofluorescent staining, HUVECs were cultured on fi-
bronectin coated dishes.
Fibronectin Degradation Assay
The degradation of fibronectin by the supernatant from Ad-TM-
FOXO3a–transfected HUVEC cultured dish was evaluated.
Cell Detachment Assay
HUVECs (1104 cells per well) were seeded on each well of the
fibronectin (5 g/cm2) precoated 96-well plates and incubated at
37°C for 6 hours to allow adhesion.
In Vivo Gene Delivery in Rabbit Carotid Arteries
In vivo gene delivery was performed in carotid arteries of New
Zealand White rabbits as previously described23 to evaluate
whether FOXO3a transduction induced EC denudation and func-
tional derangement.
Histological Analysis of Endothelial Denudation
The harvested arterial segments were stained with Evans blue to
identify the endothelium-denuded luminal surface.
Organ Chamber Analysis for Vascular Reactivity
Rings (4 mm long) from each carotid artery were used to assess
vascular reactivity. Rings were connected to isometric force dis-
placement transducers (Grass Instruments) and suspended in organ
chambers as previously described.23
Statistical Analysis
All data are expressed as mean  SD
Results
FOXO3a Induces Detachment of HUVECs from
Matrix, Leading to Anoikis
HUVECs were infected by either Ad-GFP or Ad-TM-
FOXO3a in the presence of serum and were harvested 24
hours thereafter. We found that Ad-TM-FOXO3a-transfected
HUVECs showed significant detachment from the culture
dish (Figure 1A). Survival of HUVECs was also found to
decrease using a WST-1 assay (Figure 1B). Interestingly,
Ad-TM-FOXO3a-transfected HUVECs were found to lose
contact with plates as well as with neighboring cells at early
stages after adenoviral transfection and before the appearance
of other morphological changes that are associated with
apoptosis (Figure 1C).
From these observations, we presumed that the activation
of FOXO3a might disrupt cell-to-cell and cell-to-ECM adhe-
sive interactions, leading to apoptosis. We also presumed that
MMP activation might play a role in this process, because in
microarray experiments comparing Ad-TM-FOXO3a–trans-
fected HUVECs with Ad-GFP, the MMP-3 gene was one of
the most robustly upregulated genes after FOXO3a-
transduction, whereas TIMP-1 gene expression was found
suppressed (data not shown).
To confirm whether MMPs play a main role in EC
detachment after FOXO3a-transduction, we pretreated
HUVECs with GM6001, a general MMP inhibitor, which
markedly decreased EC detachment from the plate as well as
from the neighboring cells (Figure 1D and 1E). Furthermore,
FACS analysis for hypodiploid DNA showed about 50%
reduction of apoptotic fraction in the presence of GM6001
(Figure 1F), suggesting that MMP activation might induce
anoikis in FOXO3a-transduced HUVECs.
FOXO3a Induces MMP-3 in Endothelial Cells
To confirm whether the endothelial cell detachment after
FOXO3a overexpression was mediated by MMP activation,
we evaluated the regulation of MMP-3 after FOXO3a trans-
duction. mRNA levels of MMP-3 was found to be signifi-
cantly upregulated by real-time PCR assay. The relative fold
elevation of MMP-3 transcript compared with GAPDH was
10.3 at 16 hours, 13740 at 24 hours, and 690250 at 40
hours (Figure 2A). MMP-3 protein synthesis also increased in
Ad-TM-FOXO3a–transfected HUVECs and decreased in Ad-
DN-FOXO3a–transfected HUVECs. In contrast, TIMP-1
protein expression was found to be modestly decreased in
Ad-TM-FOXO3a–transfected HUVECs and increased in Ad-
DN-FOXO3a–transfected HUVECs. (Figure 2B).
Next, we performed casein and gelatin zymography to
study whether increased MMP-3 protein retained enzymatic
activity. In the casein zymography analysis, a major band
corresponding to 57 kDa, and caused by the protease activity
of MMP-3 was increased in media from Ad-TM-FOXO3a–
transfected cells compared with media from Ad-GFP–trans-
fected cells. In contrast, transduction of dominant-negative
FOXO3a decreased MMP-3 activity in this assay (Figure 2C,
upper panel). Of note, although mRNA or protein expression
of MMP-2 or MMP-9 did not increase (data not shown),
gelatin zymography showed an increased enzymatic activity
of MMP-9 (92kDa) and MMP-2 (72kDa; Figure 2C, lower
panel). Because MMP-3 is reported to activate other MMPs
including MMP-2/MMP-9,24,25 we performed MMP-3 specific
knockdown experiments using MMP-3 siRNA. We found
MMP-2 and MMP-9 enzymatic activity decreased with MMP-3
siRNA, suggesting that MMP-3 activation contributed to in-
creased enzymatic activity of MMP-2 or MMP-9 after FOXO3a
activation. Moreover, we also found that MMP-3 specific
knockdown showed similar degree of reduction of apoptosis to
that of GM6001 (supplemental Figure IIA through IID).
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Stress to Endothelial Cells Induces Endogenous
FOXO3a-MMP-3 Activation
To examine the role of the endogenous FOXO3a-MMP regula-
tory axis during the stress response, HUVECs were subjected to
serum starvation or to heat shock without adenoviral transfec-
tion. An increase in active FOXO3a in nuclear fraction was
detected at 6 hours after the initiation of serum starvation
(supplemental Figure IIIA), which correlated with the time
course of MMP activity increase in the zymography assay
(supplemental Figure IIIB). In the nonstressed state, endogenous
FOXO3a is located in cytoplasm and where it is inactive
(supplemental Figure IIIC, left upper panel). In addition, heat
shock rapidly induced intranuclear translocation and activation
of endogenous FOXO3a by 30 minutes (supplemental Figure
IIIC, left lower panel), which can be confirmed by the increased
FOXO3a amount in nuclear fraction (supplemental Figure IIID).
Enzymatic activity of MMP-3 was also found to be increased
under these conditions (supplemental Figure IIIE). Heat shock
induced cell death, which was significantly reduced by GM6001
treatment, suggesting that FOXO3a-MMP signaling contributes
to the cytotoxicity of ECs during stress (supplemental
Figure IIIF).
FOXO3a Reduces Cell-to-ECM Interaction
To investigate whether FOXO3a activation leads to ECM
degradation, we evaluated the degradation of the matrix protein
fibronectin after FOXO3a-transduction. After 12 hours of
Ad-TM-FOXO3a transfection, fibronectin levels decreased
significantly and this downregulation was effectively re-
versed by treatment with GM6001, suggesting that the
enhanced MMP activity might contribute to the degradation
of fibronectin (supplemental Figure IVA). To examine this
regulation further, the supernatant from each culture dish was
mixed with 5 g of fibronectin and the degree of protein
degradation was measured. The supernatant from the Ad-TM-
FOXO3a–transfected culture dish displayed significantly in-
creased fibronectin-proteolytic activity. Furthermore, the en-
hanced degradation was reduced by treatment with GM6001,
suggesting these responses were mediated by a secreted
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Figure 1. Effect of FOXO3a on adhesiveness and viability of HUVEC. A, Fluorescent microscopic findings of HUVECs. Magnification
100. B, WST-1 assay of HUVEC viability. Data are expressed as meanSE (P0.01 vs Ad-GFP group, n12). C, Fluorescent micro-
scopic findings of HUVECs 15 hours after transfection with 25 MOI of Ad-TM-FOXO3. Magnification 300. D, Microscopic findings of
HUVECs 24 hours after transfection with Ad-GFP, Ad-TM-FOXO3, or Ad-TM-FOXO3 in the presence of GM6001. Magnification 200.
E, Quantitation of adhering cells. Data are presented as meanSE (P0.05 vs Ad-GFP–transfected group, n16). F, FACS analysis for
hypodiploid DNA. Ad-TM-FOXO3a, adenovirus of constitutively active triple-mutant FOXO3a; Ad-GFP, adenovirus of green fluorescent
protein; Ad-DN-FOXO3a, adenovirus of dominant negative FOXO3a.
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the functional significance of FOXO3a activation on adhesive
capacity of HUVECs to ECM, we tested the adhesive
capacity of HUVECs on fibronectin coated plates. FOXO3a
activation significantly decreased the adhesion of HUVECs
to the plates, which was reversed in the presence of GM6001
(supplemental Figure IVC).
FOXO3a Reduces Cell-to-Cell Adhesion
Next, we examined whether FOXO3a affected cell-to-cell
adhesion systems maintained by the major adhesion mole-
cules, VE-cadherin and -catenin. Figure 3A shows uniform
VE-cadherin staining over the entire cell margin, and Figure
3B shows the staining pattern of its intracellular partner
-catenin, that is present at adherens junction as well as in the
cytoplasm of HUVECs (Figure 3A and 3B, left). At 24 hours
after Ad-TM-FOXO3a transfection, the expression of both of
these molecules was decreased at the cell-cell junctions
(Figure 3A and 3B, middle). The degradation of both VE-
cadherin and -catenin was almost completely reversed in the
presence GM6001, suggesting that MMP might mediate these
response (Figure 3A and 3B, right). These morphological
changes were corroborated by immunoblot analysis of cell
lysates, which showed decreased VE-cadherin and -catenin
protein in TM-FOXO3a-transduced HUVECs and partial
reversal by GM6001 (Figure 3C).
FOXO3a Activation in the Vessel Wall Induces
Endothelial Denudation and Loss of
Barrier Function
We evaluated vascular integrity after FOXO3a activation in
rabbit carotid arteries after FOXO3a transduction. At 24
hours after Ad-TM-FOXO3a transfer, arterial segments
showed significant endothelial denudation, which was mark-
edly reversed by GM6001 (supplemental Figure VIA and
VIB). Immunohistochemical staining of PECAM-1 revealed
greater endothelial denudation after FOXO3a gene transfer
compared with the control. Endothelial denudation was sig-
nificantly reversed by GM6001, suggesting that these find-
ings were mediated by MMPs (Figure 4A, supplemental
Figure VIC). Scanning electron microscopy showed a regular
and smooth-surfaced endothelial lining in the Ad-GFP group
(Figure 4B, upper middle), similar to the endothelial lining of
a normal, uninjured carotid artery (Figure 4B, upper left). In
contrast, the luminal surface of segments harvested from the
Ad-TM-FOXO3a–transfected group demonstrated an irregu-
lar endothelial lining, exposing subendothelial tissue and
various stages of endothelial cells detached from the subcel-
lular matrix (Figure 4B, lower panels). GM6001, again,
significantly reversed these phenomena (Figure 4B, upper
right).
FOXO3a Activation Impairs Endothelial Function
Vascular rings from each carotid artery were applied to an
organ chamber system to assess both endothelium-dependent
Figure 2. FOXO3a induces MMP-3 and suppresses
TIMP-1. A, Quantification of real-time quantitative
RT-PCR assay of MMP-3. Data are presented as
meanSE of the relative fold elevation compared
with GAPDH for 3 independent experiments. B,
Immunoprecipitation and immunoblot for MMP-3
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Figure 3. FOXO3a triggers cleavage of adherens junction pro-
teins - VE-cadherin and -catenin. A and B, Immunofluores-
cent microscopy of VE-cadherin (A) and -catenin (B).
HUVECs were transfected with Ad-GFP (left), Ad-TM-FOXO3a
(middle), or Ad-TM-FOXO3a in the presence of GM6001
(right). Magnification 400. C, Immunoblot analysis of
VE-cadherin and -catenin in cell lysates.
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(Figure 4C) and endothelium-independent vasorelaxation
(Figure 4D). Both endothelium-dependent and endothelium-
independent vasorelaxation were significantly impaired in the
TM-FOXO3a–transduced vessels. However, the FOXO3a-
induced impairment of endothelium-dependent vasorelax-
ation in response to acetylcholine was much more profound
compared with the relatively mild impairment of endotheli-
um-independent vasorelaxation in response to sodium nitro-
prusside. In addition, the MMP blocker, GM6001, which
would in theory prevent cellular detachment or anoikis,
significantly reversed only the deficit in endothelium-
dependent vasorelaxation (Figure 4C) and not endothelium-
independent vasorelaxation (Figure 4D). These data suggest
that FOXO3a activation in the vessel results in a greater
impairment of endothelial-dependent vasorelaxation, and that
the profound impairment of endothelium-dependent vasore-
laxation may be related to anoikis.
Discussion
The most important finding of our study is that FOXO3a, a
major forkhead transcription factor expressed in endothelial
cells, suppressed cell-to-cell and cell-to-matrix interaction in
ECs. These data suggest a novel mechanism of FOXO3a-
induced apoptosis in endothelial cells. First, FOXO3a in-
duced detachment of ECs from ECM or adjacent ECs leading
to anoikis through degradation of major adherens junctional
proteins such as fibronectin, VE-cadherin, and -catenin.
Second, FOXO3a induced MMP-3 and suppressed TIMP-1
expression in ECs. The finding that EC detachment, disrup-
tion of ECM and resulting anoikis were significantly reversed
by GM6001, a MMP inhibitor, suggests the increased MMP
activity mediates these responses. Third, these phenomena
were also reproduced under pathophysiologic conditions. For
example, endogenous FOXO3a induction and MMP activa-
tion were observed in ECs under stressful conditions such as
serum starvation or exposure to heat shock. Finally, we
showed both in vivo and ex vivo, that FOXO3a induced
endothelial denudation and endothelial dysfunction in blood
vessels.
FOXO3a, ECM, and EC Survival
Control of apoptosis in the endothelium is a critical issue
during pathologic processes such as inflammation, vascular
remodeling, and allograft vasculopathy.26 The binding to
ECM is an important survival signal to ECs. The degradation
of the ECM proteins such as fibronectin has been shown to
affect the apoptotic program of ECs and epithelial cells.27–30
Another important element in EC survival is the adherens
junction, in which VE-cadherin anchors the cytoskeleton of
neighboring cells via - or -catenin.31–33 Both the degrada-
tion of VE-cadherin and -catenin have been observed during
apoptosis, implicating their role in apoptosis.34,35 In the
present study, we found FOXO3a activation decreased fi-
bronectin, VE-cadherin, and -catenin levels. This decrease
could be the result of the reduced synthesis of ECM, rather
than the increased degradation. In this regard, Daly et al
showed that FOXO1, another forkhead transcription factor,
regulated genes involving in the remodeling of ECM such as
decorin, lumican, and collagen type III.36 However, this
hypothesis does not explain both the rapid decrease of ECM
and adherens junction proteins after FOXO3a transduction,
nor does it explain the ability of the MMP inhibitor to
neutralize the effect of FOXO3a on cytotoxicity. Thus, we
think that degradation by MMPs plays a major role in matrix
regulation by FOXO3a.
FOXO3a and MMP3 Activation in ECs
MMPs constitute a family of extracellular proteases that are
involved both in normal physiological remodeling and in
pathologic degradation of the ECM.37 ECM degradation by
MMPs has been shown to be a signal that can induce
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Figure 4. FOXO3a activation in vessel wall induces
endothelial denudation and loss of barrier function,
impairing endothelial function. A, Representative
photographs of immunohistochemistry of blood ves-
sels with PECAM-1. Upper panel, PECAM-1 staining
of blood vessel; Middle panel, merged image of
PECAM-1 and DAPI visualizing nuclei (Magnification
40); Lower panel, enlargement of merged image
(Magnification 100). B, Scanning electron micros-
copy of luminal surface of the harvested arterial seg-
ments: normal control (upper left); treated with
Ad-GFP (upper middle); Ad-TM-FOXO3aGM6001
(upper right); Ad-TM-FOXO3a (Lower panels). Magni-
fication 350. C, Endothelium-dependent vasorelax-
ation to various concentrations of acetylcholine. D,
Endothelium-independent vasodilatation to various
concentrations of sodium nitroprusside. Each experi-
ment was repeated 3 times and presented as
meanSE.
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TIMP-1, the major negative regulator of MMPs, has been
shown to exert a potent antiapoptotic effect on ECs.39 Among
various MMPs, we suggest MMP-3 might mediate FOXO3a-
induced EC anoikis for 3 reasons. First, MMP-3 was highly
upregulated in the microarray analysis of FOXO3a-induced
genes, and this upregulation was confirmed at both mRNA
and protein levels in the present study. Second, MMP-3 has a
consensus binding site for the forkhead factors in its promoter
sequences40 suggesting transcriptional regulation by
FOXO3a. Third, we found MMP-3 levels increased after
FOXO3a activation. Other studies evaluating promoter se-
quence or microarray analysis have suggested possible regu-
lation of some MMPs by forkhead factors,40,41 and though
PI3K/Akt pathway was suggested to increase enzymatic
activity of MMPs.42,43 However, to the best of our knowl-
edge, this is the first report documenting a direct regulatory
connection between MMPs and forkhead factors.
FOXO3a and Other MMPs Activation in ECs
Interestingly, enzymatic activities of MMP-2 and MMP-9
also increased after FOXO3a activation. However, we could
not find any evidence of direct regulation of MMP-2 or
MMP-9 by FOXO3a. First, neither mRNA nor the protein
amount of MMP-2/MMP-9 changed after FOXO3a activa-
tion. Second, in the microarray data comparing Ad-TM-
FOXO3a–transfected HUVECs with either Ad-GFP or Ad-
DN-FOXO3a–transfected HUVECs, the expression pattern of
MMP-2/MMP-9 did not show any significant change (data
not shown). Third, the promoter sequences of MMP-2 or
MMP-9 do not contain the consensus binding site for the
forkhead transcription factors. Therefore, we hypothesize that
the increased enzymatic activity of MMP-2 or MMP-9
observed after FOXO3a activation involves indirect regula-
tion through changes in the expression of other molecules.
We suspected that MMP-3 activation may be responsible for
the activation of MMP-2/MMP-9, consistent with previous
findings.24,25 Indeed, we found that MMP-3 knockdown with
siRNA led to significant reduction in the enzymatic activity
of MMP-2 and MMP-9, supporting the hypothesis that
MMP-3 activation contributes to increased enzymatic activity
of MMP-2 or MMP-9 after FOXO3a activation. Moreover,
we also found that MMP-3 knockdown revealed a significant
reduction of apoptosis compared with that of GM6001,
suggesting further that MMP-3 plays a key role in FOXO3a-
induced ECM disruption. However, because MMP activity is
also regulated by other molecules, such as TIMP-1,25 we do
not exclude the possibility that the suppression of TIMP-1 or
the activation of other MMPs might result in global MMP
activation. For this reason, we decided to use the general
MMP inhibitor GM6001 to investigate the association be-
tween FOXO3a, MMP activity, and endothelial cell apopto-
sis. Finally, we cannot ascribe FOXO3a-induced apoptosis
solely to MMP activation, because blocking experiment with
GM6001 failed to completely reverse the effects of FOXO3a
on apoptosis and anoikis. However, these findings offer new
insights to the multifaceted role of FOXO3a in ECs.
In Vivo Significance of MMP Activation by
FOXO3a in ECs
We found that FOXO3a activation induced endothelial denu-
dation in vessels through in vivo gene delivery. We also
found FOXO3a activation impaired both endothelium-
dependent and endothelium-independent vasorelaxation
through ex vivo evaluation of vasoreactivity. These effects
may be caused by the proapoptotic actions of FOXO3a on
ECs7,19 as well as smooth muscle cells.17,44,45 However, the
degree of vasorelaxation impairment had a significantly
greater impact on endothelium dependent function. Further-
more, GM6001 significantly reversed endothelium-dependent
vasorelaxation, but had little or no effects on endothelium-
independent vasorelaxation, suggesting that MMP activation
may play a role in endothelial dysfunction following
FOXO3a activation in vivo.
In summary, suppression of EC-ECM or EC-EC interac-
tion represents a novel mechanism of FOXO3a-mediated EC
apoptosis. Our results also suggest that MMP activation
caused by deregulated FOXO3a expression could contribute
to endothelial dysfunction of blood vessel.
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Materials and methods 
 
Cell culture, adenoviral vectors, and siRNA 
Four to six passage human umbilical vein endothelial cells (HUVEC, Clonetics™) 
were seeded on 2% gelatin-coated (Sigma, St. Louis, MO) culture plates and incubated 
in endothelial growth medium (EGM bullet kit, Clonetics) with 10% fetal bovine serum.  
To evaluate the role of FOXO3a, an adenoviral vector expressing constitutively-active 
triple-mutant FOXO3a (Ad-TM-FOXO3a) was used as previously described1,2. Briefly, 
Ad-TM-FOXO3a was constructed by replacing three phosphorylation sites, Thr32, 
Ser253, and Ser315 with alanine residues, thus unphosphorylatable by Akt. And to 
analyze the intracellular localization or behavior of FOXO3a, we used an adenoviral 
vector expressing wild type form (Ad-WT-FOXO3a), which was also tagged with 
hemagglutinin sequence. For blocking experiment, an adenoviral vector expressing 
dominant-negative form (Ad-DN-FOXO3a), of which transactivation domain from the 
C terminus was deleted, was used. As a control, an adenoviral vector expressing green 
fluorescence protein (Ad-GFP) was used.  
For gene transduction, cells were transfected with 25MOI of the adenoviral vector. 
With this dose, we confirmed the transfection efficacy was more than 90% at 24 hours. 
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As each adenoviral vector also contained GFP sequence, transfection efficacy can be 
confirmed by visualization of the green fluorescence (GFP) of transduced cell (Figure 
1A). And we presented the baseline validation data regarding adenoviral vector in the 
supplemental figure 1. 
For specific blockage of MMP-3, MMP-3 Stealth™ RNAi (or siRNA) with 
oligofectamine™ reagents as were used following manufacturer’s instructions 
(Invitrogen). A control siRNA was also purchased from Invitrogen. Control siRNA or 
MMP-3 siRNA were treated 24 hours prior to the indicated adenovirus instillation.  
 
Cell viability and apoptosis assay 
Subconfluent HUVECs in 96-well plates were infected with adenoviral vectors and 
cell viability was quantified using tetrazolium salt, WST-1, as instructed by the 
manufacturer (Roche). Apoptosis after 24 hours of adenoviral vector transfection was 
determined by measuring the hypodiploid, fragmented, DNA content using FACS 
analysis3. For blocking experiment, we treated HUVECs with 10µM GM6001 
(Chemicon), an MMP inhibitor, for 18 hours from 6 hours post infection. 
 
Real-time PCR analysis 
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Changes in RNA-expression of MMP-3 was determined by quantitative real-time PCR 
as previously described4. Primers and probes used were as follows: forward primer: 5`-
TCT CGT TGC TGC TCA TGA AAT T-3`; reverse primer: 5`-TAG AGT GGG TAC 
ATC AAA GCT TCA G-3`; probe: 5`-6FAM-CTC CCT GGG TCT CTT TCA CTC 
AGC CA-TAMRA-3. Fold changes in gene expression were determined using the Ct 
method. To standardize the quantification of the genes, GAPDH from each sample was 
quantified and the selected genes were normalized to GAPDH.  
 
Immunoblot analysis 
Immunoblot analysis was performed by modification of the procedures described 
previously5. Primary antibodies used in this study are as follows: anti-FOXO3a (rabbit 
polyclonal IgG, Upstate Biotechnology, 1:1000), anti-MMP-3 (R&D systems) 1:500, 
anti-fibronectin 1:500 (BD transduction laboratories), anti-β-catenin 1:500 (BD 
transduction laboratories) and anti-VE-cadherin 1:500 (BD transduction laboratories). 
For immunoblot of MMP-3 and TIMP-1, immunoprecipitation was performed for 
protein concentration.  
 
Casein and gelatin zymography 
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Zymography was performed using a previously described method6. Briefly, samples of 
media conditioned by cell culture under different experimental conditions were 
separated on an 8% polyacrylamide gel containing 0.1% casein or gelatin. After 
electrophoresis, gels were stained with 0.05% Coomassie Brilliant Blue R250 (Sigma 
Co.) and the location of caseinolytic and gelationlytic activity detected as clear bands. 
 
Immunofluorescent staining 
For immunofluorescent staining, HUVECs were cultured on fibronectin coated dishes. 
After 12 hour of adenoviral transfection, HUVECs were fixed with 100% methanol for 
30 minutes at -20 , and blocked by incubation with 1% BSA in PBS for 30 minutes at ℃
room temperature. Cells were then reacted with either mouse monoclonal antibody 
against fibronectin (1:50 dilution), β-catenin (1:100 dilution), or VE-cadherin (1:100 
dilution) overnight at 4 . Cells were incubated for 1 hour with PE℃ -conjugated goat 
anti-mouse IgG antibody at a 1:50 dilution and then, with 4,6-diamidino-2-
phenylindole(DAPI) for 20 minutes to visualize nuclei. 
 
Fibronectin degradation assay. 
The degradation of fibronectin by the supernatant from Ad-TM-FOXO3a transfected 
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HUVEC cultured dish was evaluated. Supernatant from each culture plate was mixed 
with 5μg of fibronectin and incubated at 37℃ for 24 hours. The reaction was terminated 
by the addition of EDTA and the proteins were electrophoresed by 8% SDS-PAGE gel 
under reducing condition. The transferred SDS-PAGE gel was stained with Coomassie 
Brilliant Blue and the degree of digestion was evaluated by densitometry.  
 
Cell detachment assay 
HUVECs (1x104cells/well) were seeded on each well of the fibronectin (5µg/cm2) 
precoated 96 well plates and incubated at 37℃ for 6 hours to allow adhesion. After cell 
adhesion, 25 MOI of adenoviral vectors were added to each conditioned well. After 
incubation for 24 hours, detached cells were removed by two washes with PBS. 
Residual viable cells were quantified by the WST-1 assay. 
 
In vivo gene delivery in rabbit carotid arteries 
All animal experiments were performed after receiving approval of the Institutional 
Animal Care and Use Committee (IACUC) of Clinical Research Institute in Seoul 
National University Hospital (AAALAC accredited facility). And National Research 
Council (NRC) guidelines for the care and use of laboratory animals were observed 
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(revised 1996). In vivo gene delivery was performed in carotid arteries of New Zealand 
White rabbits as previously described7 to evaluate whether FOXO3a transduction 
induced EC denudation and functional derangement. Briefly, animals were given an 
intramuscular injection of ketamine (1.2mg/kg) and xylazine (0.3mg/kg) for sedation 
and anesthesia. Paramedian cervical incisions were made in the anterior neck, and the 
common carotid arteries were exposed bilaterally by blunt dissection. Branches of the 
carotid artery were tied off using 5-0 ethilon sutures. After the administration of heparin 
(100 U/kg), proximal and distal vascular clamps were applied to the carotid artery, and a 
24-gauge angiocatheter was inserted into the distal part of the isolated segment. The 
needle was withdrawn and blood removed from the segment of the artery using a gauze 
wick at the open end of the angiocatheter. A mixture containing the each adenoviral 
vector (final concentration: 3.5x109 pfu/400μL) was then instilled intraluminally via the 
catheter. After 30 minutes, vascular clamps were removed, and flow was restored. In 
case of the blocking experiments, 0.5M of GM6001 was instilled simultaneously. Six 
hours later, the animals were euthanized and carotid arteries were isolated and harvested.  
 
Histologic analysis of endothelial denudation 
The harvested arterial segments were stained with Evans blue to identify the 
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endothelium-denuded luminal surface. The endothelium-retained area was defined 
macroscopically as the area that was not stained with the Evans blue dye. Another 
portion of the harvested vessels were used for immunohistochemistry, performed as 
previously described8,9. The primary antibody used was anti-rabbit CD31 PECAM-1 
monoclonal antibody (1:200 dilution; Transduction laboratories). Each arterial specimen 
was blindly analyzed by computerized morphometry using Image Pro Plus Analyzer 
Version 4.5 (Media Cybernetics). Endothelial coverage was assessed by the percentage 
of PECAM-1 positive circumference versus total in three different sections. The extent 
of EC detachment was analyzed using scanning electron microscopy with standard 
techniques10.  
 
Organ chamber analysis for vascular reactivity 
Rings (4 mm long) from each carotid artery were used to assess vascular reactivity. 
Rings were connected to isometric force displacement transducers (Grass Instruments) 
and suspended in organ chambers as previously described7. Using acetylcholine and 
sodium nitroprusside, endothelium-dependent and endothelium-independent relaxation 
was evaluated using standard methods11.  
 by on September 2, 2009 atvb.ahajournals.orgDownloaded from 
 
Statistical analysis 
All data are expressed as mean ± SD. A 2-tailed t-test was used to compare continuous 
variables. The comparisons of means from in vitro studies were performed using the 
Mann-Whitney U test due to small sample numbers. All calculations were performed 
using SPSS 13.0, and p < 0.05 was considered statistically significant.  
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A. Confirmation of unphosphorylatable FOXO3a
Subconfluent HUVEC were infected with adenovirus 
at 25MOI each for 20 hours in EGM2%.






B. Confirmation of WT-, TM-, DN-FOXO3a
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C. Morphologic change of HUVECs 16 hours after 
transfection of the indicated adenovirus ± siRNA.








Fluorescent microscope detecting GFP.  Magnification x 200
D. FACS analysis evaluating apoptotic fraction 
16 hours after transfection of the indicated 
adenovirus ± siRNA.












































































B. Casein and gelatin zymography
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Supplemental figure 3. Endogenous FOXO3a-MMP activation under stressful conditions.
A. Serial immunoblot of endogenous FOXO3a 
after serum starvation









Heat shock 2 hour Ad-WT-FOXO3a
+ GM6001
C. Immunofluorescent staining for endogenous 
FOXO3a after heat incubation (42ºC)
D. Immunoblot FOXO3a after heat shock.
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1. Only Fibronectin,  
2. Only supernatant
3. Ad-GFP,          4. Ad-TM-FOXO3a
5. Ad-TM-FOXO3a + GM6001 (5μM)
6. Ad-TM-FOXO3a + GM6001 (10μM)
A. Immunofluorescent microscopy of fibronectin. 
Ad-GFP Ad-TM-FOXO3a




B. Fibronectin degradation 
assay. 
C. Adhesion assay. 
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1. Only Fibronectin,  
2. Only supernatant
3. Ad-GFP,          4. Ad-TM-FOXO3a
5. Ad-TM-FOXO3a + GM6001 (10μM)
1 2 3 4 5
Supplemental figure 5. Figures supplementing ‘Supplemental figure 4B’
regarding fibronectin degradation
A. Another ELISA to supplement Figure 4B 
B. TINA densitometry to supplement Figure 4B 
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A. Macroscopic photographs of the luminal surface 































































D. Representative figures among triplicated
organ chamber experiments of harvested blood 
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Legends for supplemental figures. 
 
Supplemental figure 1. Validation of adenoviral vectors 
For gene transduction, cells were transfected with 25MOI of the adenoviral vector. With 
this dose, we confirmed the transfection efficacy was more than 90% at 24 hours. As 
each adenoviral vector also contained GFP sequence, transfection efficacy can be 
confirmed by visualization of the green fluorescence (GFP) of transduced cell. 
(A) Immunoblot analysis of HUVEC transfected by either Ad-GFP, Ad-WT-FOXO3a, 
or Ad-TM-FOXO3a for phosphor-FOXO3a, total FOXO3a, and α-tubulin. Ad-
TM(triple mutant)-FOXO3a was constructed by replacing three phosphorylation sites, 
Thr32, Ser253, and Ser315 with alanine residues, thus unphosphorylatable by Akt and 
constitutively active. Bands of total FOXO3a are clear and even in both groups of 
HUVEC transfected with Ad-WT-FOXO3a and Ad-TM-FOXO3a, suggesting well-
controlled and similar transfection rates among HUVECs. Under the same transfection 
rates, phosphor-FOXO3a was well detected in Ad-WT-FOXO3a, whereas it was 
negligible in Ad-TM-FOXO3a, suggesting that WT is phosphorylatable and TM is not. 
Endogenous FOXO3a expression was observable in Ad-GFP lane when the blot was 
exposed longer. (B) Immunoblot analysis for phosphorylated form and total FOXO3a in 
 by on September 2, 2009 atvb.ahajournals.orgDownloaded from 
HUVECs transfected with three different adenoviral constructs of FOXO3a; WT [wild 
type], TM [triple mutant, unphosphorylatable], and DN [dominant negative, truncated at 
C-terminal transactivation domain]. Phosphorylated FOXO3a was observed in WT-
FOXO3a lane. The size of DN-FOXO3a is shorter than that of WT- or TM-FOXO3a. 
Endogenous FOXO3a expression was observable in Ad-GFP lane when the blot was 
exposed longer. (C) Differences in cytotoxicity on HUVEC between three adenoviral 
constructs of FOXO3a in the presence of 10% FBS. Cytotoxicity was greatest in 
HUVEC infected with Ad-TM-FOXO3a, least with Ad-DN-FOXO3a. (D) Differences 
in pro-apoptotic action on HUVEC between adenoviral constructs of FOXO3a in the 
absence of FBS. Serum deprivation-induced apoptosis was greatest in Ad-TM-FOXO3a 
and Ad-WT-FOXO3a, whereas least in Ad-DN-FOXO3a. Note that the difference 
between TM and WT becomes greater in the presence of serum than in the absence of 
serum, because WT-FOXO3a can be phosphorylated and inactivated in the presence of 
serum, but TM-FOXO3a is not. 
 
Supplemental figure 2. MMP-3 specific knock-down experiments using MMP-3 
siRNA 
(A) RT-PCR of MMP-3 16 hours after transfection with the indicated adenovirus. 
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Control siRNA or MMP-3 siRNA were treated 24 hours prior to the indicated 
adenovirus instillation. MMP-3 mRNA expression was increased after transfection of 
Ad-TM-FOXO3a, which was completely blocked by MMP-3 siRNA. (-) : no RNA 
loaded negative control (B) Casein and gelatin zymography. In casein zymography 
(upper panel), major bands of 57 kDa due to the protease activity of MMP-3 were 
clearly observed. MMP-3 enzymatic activity was clearly shown to be increased after 
transfection of Ad-TM-FOXO3a, but the increment was completely reversed by MMP-3 
siRNA. Similarly, the increased gelatinolytic activity of MMP-2 (72kDa) following 
transfection of Ad-TM-FOXO3a was also found reversed with MMP-3 siRNA. (C) 
Morphologic change of HUVECs 16 hours after transfection of the indicated adenovirus 
± siRNA. Plain (upper panels) and fluorescent (lower panels) microscopic findings of 
HUVECs 16 hours after transfection with 25 MOI of the indicated adenoviral vectors 
and the indicated siRNA. TM-FOXO3a gene trnasduction induced significant 
cytotoxicity of HUVEC, which was significantly reversed by MMP-3 siRNA. 
Magnification x 200. (D) FACS analysis for hypodiploid DNA indicating apoptotic cells. 
TM-FOXO3a gene transfer induced significant apoptosis of HUVEC, which was 
significantly reversed by MMP-3 siRNA. 
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Supplemental figure 3. Activation of endogenous FOXO3a and MMPs in ECs 
under stressful conditions.  
(A) Serial immunoblot analysis of endogenous FOXO3a in nuclear fraction and in 
cytosolic fraction from 0 to 24 hours after serum starvation without adenoviral 
transfection. Serum starvation increased nuclear FOXO3a from 6 hours, suggesting that 
stressful condition may activate FOXO3a in ECs. CREB (cyclic-AMP response element 
binding protein) indicates nuclear fraction. (B) Casein and gelatin zymography. Serum 
starvation stimulated the activities of MMP-3 and then MMP-2 time-dependently in 
ECs. (C) Immunofluorescent staining for endogenous FOXO3a after heat incubation 
(42ºC). In normal culture condition of ECs without heat shock, the endogenous 
FOXO3a located in cytoplasm, thus remaining inactive (Upper left). Heat shock rapidly 
translocated endogenous FOXO3a into nucleus, indicating activation of endogenous 
FOXO3a (Lower left). As a positive control for nuclear localization of FOXO3a, Ad-
TM-FOXO3a-transfected ECs are shown in the upper right panel. Magnification x 200. 
(D) Immunoblot analysis of FOXO3a in nuclear and cytosolic fraction after heat shock. 
Heat shock treatment induced nuclear translocation of endogenous FOXO3a in ECs. (E) 
Casein zymography for MMP-3. Heat shock treatment induced MMP-3 activity over 
time. (F) Bar graph illustrates the decreased cell viability after heat shock, which was 
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partially reversed by MMP inhibitor or DN-FOXO3a transfection. Data are expressed as 
mean ± SE (* P<0.01, n = 6). 
 
Figure 4. FOXO3a degrades fibronectin, leading to inhibition of cell-ECM 
interaction. 
(A) Immunofluorescent microscopy of fibronectin. HUVECs were transfected with 
Ad-GFP (left), Ad-TM-FOXO3a (middle), or Ad-TM-FOXO3a in the presence of 
GM6001 (right). (Magnification x 200). Bright field microscopic findings of HUVECs 
on fibronectin-coated dishes were on second rows. Middle and lower panels showed 
merged images with a fibronectin immunofluorescent image (magnification x 600). (B) 
Fibronectin degradation assay. (C) Adhesion assay. Media containing adenoviral vectors 
(25 MOI) were added to HUVEC (1x104cells/well) seeded on the fibronectin-precoated 
plates. After incubation for 24 hours, detached cell were removed and residual viable 
cells quantified by the WST-1 assay. Results are presented as mean ± SE (p < 0.05, n = 
16). 
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Supplemental figure 5. Figures supplementing Figure 4B regarding fibronectin 
degradation 
(A) Fibronectin degradation assay. 50μg of supernatant from each culture dish was 
mixed with 5μg of fibronectin and incubated at 37℃ for 24 hour. The mixture was 
transferred to SDS-PAGE gel, stained by Coomassie Blue. Supernatant from HUVEC 
transfected with Ad-TM-FOXO3a showed a significantly greater fibrinolytic activity on 
fibronectin than that from HUVEC with Ad-GFP. TM-FOXO3a-induced lysis of 
fibronectin was reversed by MMP inhibitor GM6001. (B) Quantitative data from TINA 
densitometry of 5 separate ELISA experiments show that the degree of fibronectin 
degradation was significantly different and that GM6001 significantly reversed 
FOXO3a-induced fibronectin degradation. 
 
Supplemental figure 6. Morphological and functional evaluation of endothelial 
denudation  
 (A) Macroscopic photographs of the luminal surface of the harvested arterial segments 
with Evans blue stain. Ad-GFP or Ad-TM-FOXO3a was delivered intraluminally in 
rabbit carotid arteries. Endothelium-denuded area was stained blue with the Evans blue 
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dye. (B) Densitometry of extent of denudation area, which was calculated as percentage 
of endothelium remaining area per total area in three different sections. Bar graphs show 
significant differences between three groups (P < 0.05). (C) Morphometric assessment 
of the ratio of PECAM-1-positive luminal circumference and total in three different 
sections, showing significant differences between three groups (P < 0.05). (D) 
Representative figures among triplicated organ chamber experiments of harvested blood 
vessels transfected with control Ad-GFP, Ad-TM-FOXO3a, or Ad-TM-FOXO3a + 
GM6001. Initial contractile response by epinephrine (Epi) was used to determine tissue 
viability in each carotid artery ring (left). And endothelium-dependent vasorelaxation to 
acetylcholine (middle) and endothelium-independent vasorelaxation to sodium 
nitroprusside (right) were evaluated. 
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